<DOC>
	<DOCNO>NCT01191242</DOCNO>
	<brief_summary>Methadone effective inexpensive therapy management chronic pain opioid dependence . However associate sudden , unexpected death . Two mechanism suggest , increase drug concentration blood , change heart rhythm . This study look blood sample drug level genetic component EKG 's ( noninvasive test reveals heart rhythm ) . There intervention .</brief_summary>
	<brief_title>Methadone Monitoring Insights Into Adverse Events</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>must 18 year age old ; eligible methadone treatment judge Discovery House criterion must sign informed consent methadone treatment prior approach study must sign write informed consent study willing mean return schedule followup visit pregnancy , participation clinical trial involve investigational market product 30 day prior entry study ; current use inducer/inhibitor know enzymes involved methadone metabolism use methadone 30 day prior study enrollment ; concomitant use QT prolonging drug consider treatment physician ineligible methadone treatment ; hepatic function panel indicate chronic liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>methadone</keyword>
	<keyword>genetic</keyword>
</DOC>